A Pharmacokinetic Study for Systemic Exposure of Twice Daily Topically Applied GSK2894512 Cream in Subjects With Atopic Dermatitis
Phase of Trial: Phase I
Latest Information Update: 16 May 2017
At a glance
- Drugs Tapinarof (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors GlaxoSmithKline
- 10 Nov 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 23 Oct 2015 Planned end date changed from 1 Aug 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
- 23 Oct 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.